Bay Area drugmaker says it returned its PPP cash

Under public scrutiny, the Treasury Department has refined its rules around so-called PPP loans meant to help companies hurt by the Covid-19 pandemic. That forced at least one local drug maker to rethink whether it wants the money.

Click to view original post